Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
International Urology and Nephrology
Literature
1.
Chung E, Gilbert B, Perera M, Matthew J, Roberts (2015) Premature ejaculation: a clinical review for the general physician. Aust Fam Physician 44(10):737–743PubMed
2.
Kalejaiye O, Almekaty K, Blecher G, Minhas S (2017) Premature ejaculation: challenging new and the old concepts. F1000Res 6:2084CrossRef
3.
Waldinger MD, Quinn P, Dilleen M et al (2005) A multinational population survey of intravaginal ejaculation latency time. J Sex Med 2(4):492–497CrossRef
4.
Waldinger MD, Hengeveld MW, Zwinderman AH (1994) Paroxetine treatment of premature ejaculation: a double-blind, randomized, placebo-controlled study. Am J Psychiatry 151(9):1377–1379CrossRef
5.
Althof SE, Abdo CHN, Dean J, Hackett G, McCabe M, McMahon CG, Rosen RC, Sadovsky R et al (2010) International Society for Sexual Medicine’s guidelines for the diagnosis and treatment of prematüre ejaculation. J Sex Med 7:2947–2969CrossRef
6.
Rosen RC, McMahon CG, Niedeberger C, Broderick GA, Jamieson C, Gagnon DD (2007) Correlates to the clinical diagnosis of prematüre ejaculation: results from a large observational study of men and their partner. J Urol 177:1059–1064CrossRef
7.
8.
Atan A, Basar MM, Tuncel A, Ferhat M, Agras K, Tekdogan U (2006) Comparison of efficacy of sildenafil-only, sildenafil plus topical EMLA cream, and topical EMLA-cream-only in treatment of premature ejaculation. Urology 67(2):388–391CrossRef
9.
Atan A, Başar MM, Aydoğanli L (2000) Comparison of the efficacy of fluoxetine alone vs. fluoxetine plus local lidocaine ointment in the treatment of premature ejaculation. Arch Esp Urol 53(9):856–858PubMed
10.
Murat MB, Atan A, Yildiz M, Baykam M, Aydogănli L (1999) Comparison of sertraline to fluoxetine with regard to their efficacy and side effects in the treatment of premature ejaculation. Arch Esp Urol 52(9):1008–1011
Metadata
Title
Editorial to the paper entitled “pharmacotherapy of premature ejaculation: a systematic review and network meta-analysis”
Author
Ali Atan
Publication date
01-11-2018
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 11/2018
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-018-1988-5

Other articles of this Issue 11/2018

International Urology and Nephrology 11/2018 Go to the issue

Urology - Original Paper

Efficacy and safety of low-intensity shock wave therapy in penile rehabilitation post nerve-sparing radical cystoprostatectomy: a randomized controlled trial

Urology - Review

Comparison of guideline recommendations for antimicrobial prophylaxis in urologic procedures: variability, lack of consensus, and contradictions

Nephrology - Original Paper

Decreased percentage of memory B cells is independently associated with increased susceptibility to infection in patients on maintenance hemodialysis

Nephrology - Original Paper

Relation of serum spondin-2 levels with cardiac morphology and inflammatory parameters in hemodialysis patients

Urology - Review

Pharmacotherapy of premature ejaculation: a systematic review and network meta-analysis

Correction

Correction to: Comparisons of percutaneous versus retroperitoneoscopic cryoablation for renal masses

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits